Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLFS NASDAQ:IRIX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$24.00+4.1%$20.46$17.86▼$29.62$1.13B1.97420,657 shs1.34 million shsIRIXIRIDEX$1.00-4.8%$1.11$0.87▼$1.65$18.26M0.6456,202 shs129,137 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+4.12%+13.37%+8.16%+3.31%+5.22%IRIXIRIDEX-4.76%-2.91%-4.76%-29.08%-1.96%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$24.00+4.1%$20.46$17.86▼$29.62$1.13B1.97420,657 shs1.34 million shsIRIXIRIDEX$1.00-4.8%$1.11$0.87▼$1.65$18.26M0.6456,202 shs129,137 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+4.12%+13.37%+8.16%+3.31%+5.22%IRIXIRIDEX-4.76%-2.91%-4.76%-29.08%-1.96%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLFSBioLife Solutions 2.40Hold$32.0033.33% UpsideIRIXIRIDEX 2.00Hold$3.00200.00% UpsideCurrent Analyst Ratings BreakdownLatest BLFS and IRIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/12/2026BLFSBioLife Solutions Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/4/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/20/2026BLFSBioLife Solutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLFSBioLife Solutions$96.21M12.19$0.24 per share100.66$7.62 per share3.15IRIXIRIDEX$52.67M0.33N/AN/A($0.06) per share-16.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLFSBioLife Solutions-$4.59M-$0.08N/A96.00N/A-2.80%1.81%1.65%8/6/2026 (Estimated)IRIXIRIDEX-$4.44M-$0.26N/AN/AN/A-6.23%-1,204.74%-11.03%8/6/2026 (Estimated)Latest BLFS and IRIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026IRIXIRIDEX-$0.07-$0.03+$0.04-$0.03$11.91 million$11.80 million5/7/2026Q1 2026BLFSBioLife Solutions$0.01$0.04+$0.03$0.02$25.66 million$27.50 million3/26/2026Q4 2025IRIXIRIDEX-$0.02-$0.01+$0.01-$0.01$14.74 million$14.72 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBLFSBioLife SolutionsN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLFSBioLife SolutionsN/A7.305.50IRIXIRIDEXN/A1.911.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLFSBioLife Solutions93.24%IRIXIRIDEX20.10%Insider OwnershipCompanyInsider OwnershipBLFSBioLife Solutions2.20%IRIXIRIDEX8.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLFSBioLife Solutions44048.86 million47.78 millionOptionableIRIXIRIDEX12017.40 million15.90 millionOptionableBLFS and IRIX HeadlinesRecent News About These CompaniesIRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...May 20 at 10:30 AM | finance.yahoo.comIRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call TranscriptMay 20 at 8:31 AM | insidermonkey.comIridex reaffirms $51M-$53M 2026 revenue outlook while targeting $600,000 annualized cost reductionMay 19 at 11:12 PM | seekingalpha.comIridex (IRIX) Q1 2026 Earnings TranscriptMay 19 at 11:12 PM | finance.yahoo.comIRIDEX Corporation (IRIX) Q1 2026 Earnings Call TranscriptMay 19 at 7:01 PM | seekingalpha.comIridex Reports First Quarter 2026 Financial ResultsMay 19 at 4:05 PM | globenewswire.comIRIDEX (NASDAQ:IRIX) Share Price Passes Below 200 Day Moving Average - Here's WhyMay 12, 2026 | americanbankingnews.comIridex to Report First Quarter 2026 Financial Results on May 19, 2026May 5, 2026 | globenewswire.comIridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser TechnologyApril 7, 2026 | globenewswire.comIridex's Q4 Loss Narrows Year Over Year on Retina Sales GrowthApril 1, 2026 | zacks.comIRIDEX CorporationMarch 31, 2026 | cnn.comIRIDEX Corporation (NASDAQ:IRIX) Q4 2025 Earnings Call TranscriptMarch 27, 2026 | insidermonkey.comIridex outlines $51M-$53M 2026 revenue target as manufacturing shift and cost cuts drive positive cash flowMarch 27, 2026 | seekingalpha.comIRIDEX (IRIX) Q4 2025 Earnings Call TranscriptMarch 27, 2026 | fool.comIRIDEX Corporation (IRIX) Q4 2025 Earnings Call TranscriptMarch 26, 2026 | seekingalpha.comIridex Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 26, 2026 | globenewswire.comIridex Signs Long-Term Lease for New HeadquartersMarch 13, 2026 | tipranks.comIridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026March 12, 2026 | globenewswire.comIridex Announces Plans to Relocate HeadquartersFebruary 2, 2026 | globenewswire.comIridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025January 12, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBLFS and IRIX Company DescriptionsBioLife Solutions NASDAQ:BLFS$24.00 +0.95 (+4.12%) Closing price 05/20/2026 04:00 PM EasternExtended Trading$24.50 +0.50 (+2.08%) As of 05/20/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.IRIDEX NASDAQ:IRIX$1.00 -0.05 (-4.76%) Closing price 05/20/2026 04:00 PM EasternExtended Trading$1.03 +0.03 (+3.00%) As of 05/20/2026 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
